Esperion Therapeutics (ESPR) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.5
-0.22
0.06
0.34

Details

Expected EPS
-0.175272
Actual EPS
-0.15
Surprise EPS
0.03
Surprise Percent
+14.42%

Description

⁨Esperion Therapeutics⁩ (⁦ESPR⁩) has reported earnings of ⁦-0.15⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts